Details for 2016020363

Up to date per 03.04.2026

Actions

Title / Product Name

FORMULIERUNGEN AUS BENDAMUSTIN

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2016020363

EP Publication Number

3158991

E-Number

1371577

Language

PCT Number

Publication Date

26.04.2017 A

17.03.2021 B1

Registration Date

17.03.2021

AT Publication Date

15.04.2021

Application Date

28.01.2011

Registration Number

Priorities

28.01.2010

299100 P

IPC

A61K 9/08 20060101AFI20170222BHEP

Maximum Duration of Protection

28.01.2031

Owner

Eagle Pharmaceuticals, Inc.50 Tice Boulevard Woodcliff Lake, NJ 07677US

Representative

Haffner und Keschmann Patentanwälte GmbHSchottengasse 3a1010 WienAT

Inventor

Palepu, Nagesh R.30 Addis Drive Southampton, Pennsylvania 18966US

Buxton, Philip Christopher11 Bradley Close Great Dunmow, Essex CM6 2PBGB

Information about Fees